Skip to content

Drug interactions

Elagolix + Everolimus

Severity: Moderate

Elagolix and Everolimus: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Elagolix has opposing effects, inhibiting P-glycoprotein while weakly to moderately inducing CYP3A4, so the net effect on everolimus exposure is unpredictable. Concentrations could rise or fall.

What this interaction means in plain words

Elagolix and Everolimus can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Elagolix belongs to Musculoskeletal; Everolimus belongs to Oncology.

Evidence level: Low

Why it happens

Elagolix inhibits P-glycoprotein and induces CYP3A4, with variable net effect on everolimus.

What to do

Monitor everolimus trough concentrations after starting or stopping elagolix and adjust the dose accordingly.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Elagolix and Everolimus, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Elagolix with Everolimus?

MediHelp rates the interaction as moderate. Elagolix and Everolimus can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Elagolix has opposing effects, inhibiting P-glycoprotein while weakly to moderately inducing CYP3A4, so the net effect on everolimus exposure is unpredictable. Concentrations could rise or fall.

How serious is the interaction between Elagolix and Everolimus?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor everolimus trough concentrations after starting or stopping elagolix and adjust the dose accordingly.

What other medicines interact with Everolimus?

MediHelp also lists interactions of Everolimus with, for example, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal, Levoketoconazole. The full list is on the Everolimus page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in